Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Jacobs

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|January 9, 2019
Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: Does β-Lactam Class Matter?Thomas J Dilworth, Anthony M Casapao, Omar M Ibrahim, et al.
Journal of the American Pharmacists Association : Japha|March 8, 2022
Implementation and evaluation of social determinants of health practice models within community pharmacyAmanda A Foster, Christopher J Daly, Tripp Logan, et al.
BMC Health Services Research|April 27, 2021
Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction programChi-Hua Lu, Collin M Clark, Ryan Tober, et al.
Open Forum Infectious Diseases|January 30, 2020
Impact of <i>Pseudomonas aeruginosa</i> Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease CohortDavid M Jacobs, Heather M Ochs-Balcom, Katia Noyes, et al.
Journal of Studies on Alcohol and Drugs|April 8, 2025
Predictors of the Rapid vs Longer Term Development of Opioid Use Disorder or Overdose among Clients Treated for an Alcohol Use ProblemZackary Falls, Xueqing Zhang, David M Jacobs, et al.
Drug and Alcohol Dependence Reports|September 17, 2024
High-risk use of prescription opioids among patients treated for alcohol problems in New York State. A repeated cross-sectional study, 2005-2018Tzu-Yin Kuo, Chi-Hua Lu, Zackary Falls, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 17, 2013
Significant publications on infectious diseases pharmacotherapy in 2012Dana R Bowers, Andrew S Hunter, David M Jacobs, et al.
International Journal of Antimicrobial Agents|October 6, 2014
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrationsJoseph A Paladino, David M Jacobs, Ryan K Shields, et al.
Clinical Pharmacology : Advances and Applications|August 17, 2022
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid ResponseFilip Stefanovic, Andres Gomez-Caminero, David M Jacobs, et al.
Journal of Biomedical Informatics|July 16, 2023
A cohort of patients in New York State with an alcohol use disorder and subsequent treatment information - A merging of two administrative data sourcesChi-Hua Lu, Gail Jette, Zackary Falls, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|January 9, 2019
Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: Does β-Lactam Class Matter?Thomas J Dilworth, Anthony M Casapao, Omar M Ibrahim, et al.
Journal of the American Pharmacists Association : Japha|March 8, 2022
Implementation and evaluation of social determinants of health practice models within community pharmacyAmanda A Foster, Christopher J Daly, Tripp Logan, et al.
BMC Health Services Research|April 27, 2021
Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction programChi-Hua Lu, Collin M Clark, Ryan Tober, et al.
Open Forum Infectious Diseases|January 30, 2020
Impact of <i>Pseudomonas aeruginosa</i> Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease CohortDavid M Jacobs, Heather M Ochs-Balcom, Katia Noyes, et al.
Journal of Studies on Alcohol and Drugs|April 8, 2025
Predictors of the Rapid vs Longer Term Development of Opioid Use Disorder or Overdose among Clients Treated for an Alcohol Use ProblemZackary Falls, Xueqing Zhang, David M Jacobs, et al.
Drug and Alcohol Dependence Reports|September 17, 2024
High-risk use of prescription opioids among patients treated for alcohol problems in New York State. A repeated cross-sectional study, 2005-2018Tzu-Yin Kuo, Chi-Hua Lu, Zackary Falls, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 17, 2013
Significant publications on infectious diseases pharmacotherapy in 2012Dana R Bowers, Andrew S Hunter, David M Jacobs, et al.
International Journal of Antimicrobial Agents|October 6, 2014
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrationsJoseph A Paladino, David M Jacobs, Ryan K Shields, et al.
Clinical Pharmacology : Advances and Applications|August 17, 2022
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid ResponseFilip Stefanovic, Andres Gomez-Caminero, David M Jacobs, et al.
Journal of Biomedical Informatics|July 16, 2023
A cohort of patients in New York State with an alcohol use disorder and subsequent treatment information - A merging of two administrative data sourcesChi-Hua Lu, Gail Jette, Zackary Falls, et al.
Pageof 10